tirzepatide ban TGA proposes on injectable compounded drugs like Ozempic and Mounjaro FDA Ban on Compounded GLP-1

Big news: The World Health Organization (WHO) has released its first global guideline on using GLP-1based medicines to treat obesity redefining obesity as a chronic, relapsing disease that deserves long-term care

Purpose of Review: This article summarizes the medical management of obesity with an emphasis on incretin-based therapeutics that target the neuro-hormonal basis of obesity.Recent Findings: Medications that mimic the effect of incretins, a group of peptide hormones released in response to nutrient intake that regulate appetite, result in potent and durable weight loss

Diet-induced weight loss (WL) leads to increased hunger and reduced fullness feelings, increased ghrelin and reduced satiety peptides concentration (glucagon-like peptide-1 (GLP-1), cholecystokinin (CCK) and peptide YY (PYY))

there is an urgent need in elucidating the pathogenic mechanisms of these diseases and deploy personalized treatments

for weight loss, Ozempic is one of the most popular new drugs in America, and there isn’t enough Ozempic for everyone who wants it

Hims Hers provides increased access to safe and affordable weight loss treatment at up to a 50% discount to help the heroes in their communities with their health and wellness